GRIN2B and melanoma: The existence of mutations in glutamate receptors was described in prior exome sequencing studies [16], and our data not only confirmed that GRIN2A was mutated in melanoma (5 out of 28 cases) but also showed that GRIN2B was recurrently mutated (Figure 2).